SCHEMBL4766345

SCHEMBL4766345

NC(=O)[C@H](CO)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.46
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.43
SCN9A Q15858 2/20 0.42
FPR2 P25090 1/20 0.42
ATR Q13535 2/20 0.41
F2 P00734 1/20 0.41
F12 P00748 1/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 1/20 0.41
VCP P55072 1/20 0.40
CYP1A2 P05177 3/20 0.39
SCN5A Q14524 1/20 0.39
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766379 1.00 CYP2A6 (0.46) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773536 0.83 CYP2A6 (0.44) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773513 0.83 CYP2A6 (0.44) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4775017 0.83 CYP2A6 (0.44) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL3962124 0.83 CYP2A6 (0.46) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4774839 0.83 DYRK1A (0.51) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4771528 0.82 RAB9A (0.46) NPC1TP53RAB9ASMN1; SMN2TSHR
SCHEMBL4776020 0.82 CDK4 (0.49) SMN1; SMN2SCN9AKMT2ASYK
SCHEMBL4771519 0.79 CYP2A6 (0.40) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4773182 0.79 CYP2A6 (0.39) CYP2A6NPC1TP53RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed